Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Net Cash Flow (2024 - 2026)

Updated

Translational Development Acquisition's Net Cash Flow was -$27.56 million in Q2 2026, compared with -$171,345 a year earlier.

Analysis

Translational Development Acquisition (TDACU) Net Cash Flow (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Translational Development Acquisition's Net Cash Flow was -$27.67 million through Jun 30, 2026; for FY2025, it was -$408,387.

  • In earlier years, Net Cash Flow was $436,153 in FY2024 and -$204.00 in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Net Cash Flow in data going back to Q3 2024.
  • Per Business Quant data, TDACU's Net Cash Flow in the three quarters before Q2 2026 was -$5,157 (Q1 2026), -$17,363 (Q4 2025) and -$88,105 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.56 Mn
Mar 31, 2026 -5,157.00
Dec 31, 2025 -17,363.00
Sep 30, 2025 -88,105.00
Jun 30, 2025 -171,345.00
Mar 31, 2025 -231,574.00
Dec 31, 2024 174.44 Mn
Sep 30, 2024 192,500.00
API Access

Translational Development Acquisition Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=TDACU&period=max&api_key=YOUR_API_KEY